¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oocyte maturation inhibitor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® maturation ÇÑ±Û ¼º¼÷
¼³¸í   
  1. ½ÅüÀû È¤Àº Á¤½ÅÀûÀ¸·Î Æø³ÐÀº °³³ä¿¡¼­ÀÇ ¹ß´Þ°úÁ¤ÀÇ ÃÖÁ¾´Ü°è¸¦ ÀǹÌÇÑ´Ù. ¹ß´ÞÀº ¸ðµç »ç¶÷¿¡°Ô °øÅëÀûÀΠÇö»óÀÌÁö¸¸ ±× ¹ß´Þ¼Óµµ¿¡´Â °³Àο¡ µû¶ó Â÷À̰¡ ÀÖ´Ù. 2. »ý¹°ÀÌ °¢°¢ Á¾À¸·Î¼­ÀǠƯ¡À» ÃæºÐÈ÷ ¹ßÈÖÇÒ ¼ö ÀÖ°Ô µÇ´Â °Í. ½Ä¹°ÀÇ ¼º¼÷Àº ²ÉÀÌ ÇÇ°í ¿­¸Å¸¦ ¸ÎÀ» ¼ö Àִ »óŰ¡ µÇ´Â °ÍÀ» ¸»Çϰí, µ¿¹°ÀÇ °æ¿ìµµ »ý½Ä´É·ÂÀ» °¡Áø »óÅ·Π¿©·¯ °¡Áö ÇüÁúÀÌ ¿Ï¼ºµÇ´Â °ÍÀ» ¸»ÇÑ´Ù. »ç¶÷ÀÇ ¼º¼÷Àº Á¤½ÅÀû-À°Ã¼ÀûÀ¸·Î´Â ¿ÏÀüÇÑ ¼º¼÷À» ÀÌ·çÁö ¾Ê¾Ò´Âµ¥µµ ¼ºÀûÀ¸·Î ¼º¼÷Çϴ ¼ö°¡ ÀÖ´Ù. À̸¥¹Ù »çÃá±â°¡ µÇ¸é ³²Àڴ 15~16¼¼¿¡ ¸ñ¼Ò¸®°¡ º¯Çϱ⠽ÃÀÛÇÏ°í ¼ö¿°µµ ÁøÇϰԠµÇ¸ç, °íȯÀº Á¤ÀÚ¸¦ ¸¸µé°Ô µÈ´Ù. ¿©Àڴ ÀÌ ¹«·ÆÀÌ µÇ¸é ÇÇÇÏÁö¹æÀÌ ¸¹¾ÆÁö°í ¸ö¸Åµµ °®Ãß¾îÁö¸ç À¯¹æµµ Ä¿Áö°í, ³­¼Ò ³»¿¡´Â ¸¹Àº ³­ÀÚ°¡ ÃàÀûµÇ¾î ÇÑ´Þ¿¡ Çѹø¾¿ ¹è¶õÀ» ÇϰԠµÈ´Ù. »ç¶÷ÀÇ À°Ã¼ÀûÀΠ¼º¼÷Àº ³²Àڴ 24~25¼¼, ¿©Àڴ À̺¸´Ù Á¶±Ý ºü¸£´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte maturation inhibitor
    ³­ÀÚ¼º¼÷¾ïÁ¦ÀÎÀÚ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte
    ³­¸ð¼¼Æ÷, ³­ÀÚ
  • oocyte donation
    ³­ÀÚ±âÁõ
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
  • maturation
    ¼º¼÷
  • maturation arrest
    ¼º¼÷Á¤Áö
  • maturation division
    ¼º¼÷ºÐ¿­
  • sexual maturation
    ¼º¹ß´Þ, ¼ºÀû¼º¼÷
  • angiotensin converting enzyme inhibitor
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • competitive inhibitor
    °æÀï¾ïÁ¦Á¦
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • corrosion inhibitor
    ºÎ½Ä¾ïÁ¦Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maturation
    ¼º¼÷
  • sexual maturation
    ¼º¹ß´Þ, ¼ºÀû¼º¼÷
  • oocyte donation
    ³­ÀÚ±âÁõ
  • inhibitor
    ¾ïÁ¦Á¦
  • selective serotonin reabsorption inhibitor
    ¼±Åü¼·ÎÅä´ÑÀçÈí¼ö¾ïÁ¦Á¦
  • oocyte
    ³­¸ð¼¼Æ÷
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte maturation inhibitor
    ³­ÀÚ¼º¼÷¾ïÁ¦ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte
    ³­¸ð¼¼Æ÷
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
  • trinucleated oocyte
    »ïÇÙ³­¸ð¼¼Æ÷
  • maturation arrest
    ¼º¼÷Á¤Áö
  • maturation division
    ¼º¼÷ºÐ¿­
  • maturation
    ¼º¼÷
  • sexual maturation
    ¼º¹ß´Þ, ¼ºÀû¼º¼÷
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
  • competitive inhibitor
    °æÀï¾ïÁ¦Á¦
  • complement inhibitor
    º¸Ã¼¾ïÁ¦Á¦, µµ¿òü¾ïÁ¦Á¦
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • corrosion inhibitor
    ºÎ½Ä¾ïÁ¦Á¦
  • enzyme inhibitor
    È¿¼Ò¾ïÁ¦Á¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological maturation
    ¸é¿ªÇÐÀû¼º¼÷
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷, ÀÏÂ÷<Á¦ÀÏ>³­¸ð¼¼Æ÷(ìéó­<ð¯ìé>Õ°Ù½á¬øà).
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
  • ACEI : angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦(ï®ü½ý£áÈåäð¤ð¥).
  • CAI=£¾carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼ÒÀúÇØ¾à, ź»êÅ»¼öÈ¿¼ÒÀúÇØ¹°Áú.
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • MAO inhibitor
    ¸ð³ë¾Æ¹Î»êÈ­È¿¼Ò ¾ïÁ¦Á¦.
  • MAO inhibitor
    ¸ð³ë¾Æ¹Î »êÈ­È¿¼Ò ÀúÇØÁ¦.
  • MAO inhibitor(MAOI)
    ´Ü°¡¾Æ¹Î»êÈ­È¿¼Ò¾ïÁ¦Á¦
  • RIMA, see reversible inhibitor of MAO-A
    °¡¿ªÀû ´Ü°¡¾Æ¹Î-A »êÈ­È¿¼Ò¾ïÁ¦Á¦
  • acetylcholinesterase inhibitor
    ¾Æ¼¼Æ®Äݸ°¿¡½ºÅÍ·¹À̽º<¿¡½ºÅ×¶óÁ¦> ¾ïÁ¦Á¦.
  • activated protein C inhibitor
    Ȱ¼ºÈ­´Ü¹éÁú C ¾ïÁ¦Á¦
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • growth inhibitor
    ¼ºÀå<¹ßÀ°>¾ïÁ¦¹°Áú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte maturation inhibitor (OMI)
    ³­ÀÚ ¼º¼÷¾ïÁ¦ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte
    ³­ÀÚ
  • oocyte
    ³­(ÀÚ)(¼¼Æ÷)(Õ°(í­)(á¬øà)).
  • oocyte
    ³­¸ð(ÑëÙ½)¼¼Æ÷
  • oocyte
    ³­ÀÚ, ³­¸ð¼¼Æ÷(Õ°Ù½á¬øà).
  • oocyte
    ³­¸ð¼¼Æ÷
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷, ÀÏÂ÷<Á¦ÀÏ>³­¸ð¼¼Æ÷(ìéó­<ð¯ìé>Õ°Ù½á¬øà).
  • primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
  • secondary oocyte
    ÀÌÂ÷³­¸ð¼¼Æ÷(ì£ó­Õ°Ù¾ á¬øà).
  • secondary oocyte
    ÀÌÂ÷³­¸ð¼¼Æ÷
  • secondary oocyte, metaphase ii
    ÀÌÂ÷³­¸ð¼¼Æ÷, ÀÌÂ÷°¨¼öºÐ¿­Áß±â
  • trinucleated oocyte
    »ïÇÙ¼º ³­¸ð¼¼Æ÷(ß²ú·àõÕ°Ù½á¬øà).
  • cell maturation
    ¼¼Æ÷¼º¼÷
  • erythrocyte maturation factor
    ÀûÇ÷±¸¼º¼÷ÀÎÀÚ(?ËÛËàËöËö).
  • erythrocyte maturation factor
    ÀûÇ÷±¸¼º¼÷ÀÎÀÚ(¡­à÷âÙì×í­).
  • immunological maturation
    ¸é¿ªÇÐÀû¼º¼÷
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MATURATION OF GAMETE
    »ý½ÄÀÚ¼º¼÷
    [¿¾ ¿ë¾î] »ý½ÄÀÚ¼º¼÷
  • Maturation division
    ¼º¼÷ºÐ¿­
    [¿¾ ¿ë¾î] ¼º¼÷ºÐ¿­
  • Secondary oocyte
    ÀÌÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­¸ð¼¼Æ÷
  • Secondary oocyte, Metaphase II
    ÀÌÂ÷³­¸ð¼¼Æ÷, ÀÌÂ÷°¨¼öºÐ¿­Áß±â
    [¿¾ ¿ë¾î] Á¦À̳­¸ð¼¼Æ÷,ÀÌÂ÷Áß±â
  • Primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­¸ð¼¼Æ÷
  • Oocyte
    ³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ³­¸ð¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oocyte
    ³­ÀÚ(Õ°í­)
  • erythrocyte maturation factor
    ÀûÇ÷±¸ ¼º¼÷ ÀÎÀÚ (îåúìϹà÷âÙì×í­)
  • maturation
    ¼º¼÷(à÷âÙ)
  • maturation-defective mutant
    ¼º¼÷°áÇÔ º¯ÀÌÁ¾(à÷âÙÌÀùèܨì¶ðú)
  • maturation factor
    ¼º¼÷ÀÎÀÚ(à÷âÙì×í­)
  • maturation protein
    ¼º¼÷´Ü¹éÁú(à÷âÙÓ±ÛÜòõ)
  • RNA maturation
    RNA ¼º¼÷(à÷âÙ)
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • Bowman-Birk inhibitor
    "º¸¿ì¸¸-¹÷Å© ÀúÇØÀÚ(îÁúªí­), º¸¿ì¸¸-¹÷Å© ÀúÇØÁ¦(îÁúªð¥)"
  • competitive inhibitor
    °æÇÕÀúÇØÁ¦(ÌæùêîÁúªð¥)
  • enzyme-inhibitor complex
    È¿¼Ò-ÀúÇØÁ¦ º¹ÇÕü (ý£áÈîÁúªð¥ÜÜùêô÷)
  • heme-controlled inhibitor
    Èû-Á¦¾î(ð¤åÙ) ÀúÇØÁ¦(îÁúªð¥)
  • inhibitor
    ÀúÇØÁ¦(îÁúªð¥)
  • inhibitor constant
    ÀúÇØÁ¦»ó¼ö(îÁúªð¥ßÈâ¦)
  • irreversible inhibitor
    ºñ°¡¿ª ÀúÇØÁ¦(ުʦæ½îÁúªð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦Á¦, ¾ïÁ¦¹°Áú, ¾ïÁ¦ÀÎÀÚ, ¾ïÁ¦½Å°æ, ¾ïÁ¦À¯ÀüÀÚ, ¾ïÁ¦¾à
  • oocyte
    ³­ÀÚ, ³­¸ð¼¼Æ÷
  • bone maturation
    °ñ¼ºÀå
  • maturation
    ¡ì»ýüÀÇ¡í¼º¼÷ , È­³ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OMI Oocyte Maturation Inhibitor
AML Acute Myelogenous Leukemia
  Morphologic Classification(FABºÐ·ù)
   &n...
BPTI basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
ESI elastase-specific inhibitor; enzyme substrate inhibitor; epidural steroid injection
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OMI Oocyte Maturation Inhibitor
COC Cumulus oocyte complex
OCC oocyte cumulus complex
OPU oocyte pick-up
GMF Glia Maturation Factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oocyte
    ³­ÀÚ, ³­¸ð ¼¼Æ÷
    ³­ ¼¼Æ÷ ¹ß´ÞÀÇ µÎ ´Ü°è ÁßÀÇ Çϳª. Á¦ 1³­¸ð¼¼Æ÷´Â Ãâ»ý °¡±îÀÌ¿¡ ³­¸ð¼¼Æ÷°¡ ºÐÈ­µÇ¾î Çü¼ºµÈ´Ù. Á¦ 2³­¸ð¼¼Æ÷´Â Á¦ 1±ØÃ¼¸¦ ºÐ¸®½ÃŰ´Â ºÐ¿­¿¡ ÀÇÇØ ¹è¶õ Á÷Àü¿¡ Á¦ 1³­¸ð¼¼Æ÷·ÎºÎÅÍ Çü¼ºµÈ´Ù. ¹è¶õ ÈÄ ¼öÁ¤ÀÌ ÀϾ¸é, Á¦ 2³­¸ð¼¼Æ÷´Â ³­ ¼¼Æ÷¿Í Á¦ 2±ØÃ¼·Î ºÐ¿­Çϸç, ¼öÁ¤ÀÌ ÀϾÁö ¾ÊÀ¸¸é »ç¸êÇÑ´Ù.
  • bone maturation
    °ñ ¼ºÀå
  • maturation arrest
    ¼º¼÷ Á¤Áö
  • maturation factor
    ¼º¼÷ ÀÎÀÚ
  • maturation period
    ¼º¼÷±â
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ ÀÀ°í °áÇÕü
  • C1-esterase inhibitor
    C1-esterase ¾ïÁ¦ ¹°Áú
  • cell wall inhibitor
    ¼¼Æ÷ º® ÇÕ¼º ¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°í ÀÎÀÚ ¾ïÁ¦Á¦
  • collagenase inhibitor
    Äݶó°Ô³ªÁ¦ ¾ïÁ¦ ¹°Áú
  • cyclooxygenase inhibitor
    »çÀÌŬ·Î¿Á½ÃÁö³×ÀÌÁî ¾ïÁ¦Àç
  • dopa decarboxylase inhibitor
    µµÆÄ µ¥Ä«¸£º¹½Ç·¹À̽º ¾ïÁ¦ÀÚ
  • lipoxygenase inhibitor
    ¸®ÆÜ½ÃÁö³×À̽º ¾ïÁ¦Á¦
  • metabolic inhibitor
    ´ë»ç ÀúÇØÁ¦, ´ë»ç ¾ïÁ¦Á¦
  • polymerization inhibitor
    ÁßÇÕ ±ÝÁöÁ¦
    ÁßÇÕ ¹ÝÀÀÀ» ¹æÇØÇϱ⵵ Çϰí, ÁßÁöÇÒ ¼ö ÀÖ´Â ¹°Áú.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
primary oocyte <cell biology, gynaecology> The enlarging ovum before maturity is reached, as opposed to the secondary oocyte or polar body.
(18 Nov 1997)
secondary oocyte <gynaecology> An oocyte which arises from the primary oocyte (which was diploid) after it completes the first meiotic division after the body has become sexually mature.
The secondary oocyte eventually divides into the mature egg or ovum (which is haploid) and a polar body (which degenerates), thus ending the second meiotic division.
(13 Nov 1997)
oocyte The developing female gamete before completion and release. The female germ cells in stages between the prophase of the first maturation division and the completion of the second maturation division.
(21 Jun 2000)
oocyte donation <gynaecology> Transfer of egg cell from donor to host mother. Oocytes are captured by laparoscopy, fertilised in vitro, and transferred to the recipient.
Used for women with premature ovarian failure or severe genetic disorders, women who respond poorly to human menopausal gonadotropin, and women older than 40 years who do not conceive with use of other therapies.
(21 Jun 2000)
oocyte expression <molecular biology> Technique whereby the cellular machinery of an oocyte (typically that of Xenopus) is utilised to transcribe functional protein from microinjected RNA.
(18 Nov 1997)
maturation 1. Achievement of full development or growth.
2. Developmental changes that lead to maturity.
3. Processing of a macromolecule; e.g., posttranscriptional modification of RNA or posttranslational modification of proteins.
Origin: L. Maturatio, a ripening, fr. Maturus, ripe
(05 Mar 2000)
maturation arrest Cessation of complete differentiation of cells at an immature stage; in spermatogenic maturation arrest, the seminiferous tubules contain spermatocytes, but no spermatozoa develop.
(05 Mar 2000)
maturation factor <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism.
(27 Sep 1997)
maturation index An index indicating the degree of maturation attained by the vaginal epithelium as adjudged by the cell types being exfoliated; serves as an objective means of evaluating hormonal secretion or response; represents the percentage of parabasal cells/intermediate cells/superficials, in that order; "shift to the left" indicates more immature cells on the surface (atrophy), while "shift to the right" indicates more mature epithelium.
(05 Mar 2000)
maturation-promoting factor <enzyme> A protein kinase that drives both the mitotic and meiotic cycles in all eukaryotic organisms.
In meiosis it induces immature oocytes to undergo meiotic maturation. In mitosis it has a role in the G2/M phase transition. Once activated by cyclins, maturation-promoting factor directly phosphorylates some of the proteins involved in nuclear envelope breakdown, chromosome condensation, spindle assembly, and the degradation of cyclins.
The catalytic subunit of maturation-promoting factor is protein p34cdc2.
Acronym: MPF
(12 Dec 1998)
maturation value An indicator of the level of maturation attained by vaginal epithelium and used as a factor in cytohormonal evaluation from the maturation index by valuing the parabasal cells at 0.0, the intermediate cells at 0.5, and the superficial cells at 1.0; for special investigations, subtypes of a major cell can be given different values's.
(05 Mar 2000)
sex maturation Achievement of full sexual capacity. Applies to animals and humans.
(12 Dec 1998)
sperm maturation Posttesticular ripening of spermatozoa.
(12 Dec 1998)
erythrocyte maturation factor <biochemistry> Member of the water soluble B vitamin group, important in the proper function of the nervous system and important in proper carbohydrate, protein and fat metabolism.
(27 Sep 1997)
a1-trypsin inhibitor A glycoprotein that is the major protease inhibitor of human serum, is synthesised in the liver, and is genetically polymorphic due to the presence of over 20 alleles; individuals appropriately homozygous are deficient in a1-trypsin and are predisposed to pulmonary emphysema and juvenile hepatic cirrhosis because of alterations in the amino acid and sialic acid components of the glycoprotein. A1-Antitrypsin also inhibits thrombin.
Synonym: a1-trypsin inhibitor, human a1-proteinase inhibitor.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦ÀÚ(¹°);¹ÝÀÀ¾ïÁ¦Á¦
  • maturation
    È­³ó (°úÀÏÀÇ µûÀ§ÀÇ) ÀÍÀ½;(Àç´ÉÀÇ) ¿ø¼÷
  • oocyte
    ³­¸ð ¼¼Æ÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á